核酸ベースの遺伝子治療の世界市場レポート 2025年

核酸ベースの遺伝子治療の市場規模は、今後数年で急成長が見込まれます。2029年には13億3,000万米ドルに成長し、CAGRは10.7%となります。予測期間の成長は、適応症の拡大、資金調達の増加、患者擁護と意識向上、遺伝子治療研究開発への投資拡大、遺伝子治療応用範囲の拡大、希少疾患などに起因します。予測期間の主な動向には、体外遺伝子編集、体内遺伝子編集の進歩、併用療法、標的送達システム、希少疾患の遺伝子編集、非ウイルスベクターなどがあります。

核酸ベースの遺伝子治療市場は、政府と企業の両方からの財政的支援の増加により、需要の増加が見込まれています。遺伝子発現を担う天然由来の酸やタンパク質を模倣する核酸治療薬は、嚢胞性線維症、血友病、鎌状赤血球貧血、サラセミア、糖尿病など、従来の治療法では治療法のない疾患の治療に有望なアプローチを提供します。これらの治療法は、疾患の遺伝的基盤を標的とし、永久的な解決策となる可能性を秘めています。例えば、米国立衛生研究所（NIH）は2022年8月、HIV治療研究を推進するため、5年間で年間3,400万米ドルを投資すると発表しました。遺伝子治療に対するこうした政府の支援や投資は、核酸ベースの遺伝子治療市場を押し上げると予想されます。

ヘルスケア支出の拡大は、核酸ベースの遺伝子治療市場の今後の成長を牽引するとみられます。ヘルスケア支出は、ヘルスケアシステムや経済圏内のヘルスケア関連商品やサービスに対する総支出を包含し、核酸遺伝子治療の開発とアクセシビリティを支える上で重要な役割を果たしています。2022年、米国のヘルスケア支出は3,310億米ドルに達したと、カナダ健康情報研究所が報告しています。このヘルスケア支出の増加は、核酸遺伝子治療市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の核酸ベースの遺伝子治療市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の核酸ベースの遺伝子治療市場：成長率分析
• 世界の核酸ベースの遺伝子治療市場の実績：規模と成長、2019～2024年
• 世界の核酸ベースの遺伝子治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の核酸ベースの遺伝子治療市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：最終用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：アンチセンスとアンチジーンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：短鎖阻害配列（siRNA）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：遺伝子導入療法のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：ヌクレオシド類似体のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：リボザイムのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：アプタマーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年

第7章 地域別・国別分析

• 世界の核酸ベースの遺伝子治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の核酸ベースの遺伝子治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 バングラデシュ市場

第16章 タイ市場

第17章 ベトナム市場

第18章 マレーシア市場

第19章 シンガポール市場

第20章 フィリピン市場

第21章 香港市場

第22章 ニュージーランド市場

第23章 西欧市場

第24章 英国市場

第25章 ドイツ市場

第26章 フランス市場

第27章 イタリア市場

第28章 スペイン市場

第29章 スペイン市場

第30章 オーストリア市場

第31章 ベルギー市場

第32章 デンマーク市場

第33章 フィンランド市場

第34章 アイルランド市場

第35章 オランダ市場

第36章 ノルウェー市場

Gene therapy aims to correct faulty genes responsible for disease development, while nucleic acid-based therapeutics are employed to address genetic disorders and conditions without a definitive cure, such as anemia, sickle cell disease, cystic fibrosis, and thalassemia.

The key technologies include anti-sense and anti-gene strategies, short inhibitory sequences, gene transfer therapy, nucleoside analogues, ribozymes, aptamers, and other innovative approaches. Nucleoside analogues, a significant class of antiviral agents, are commonly utilized to combat conditions like human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and cytomegalovirus (CMV) infections. These therapeutic approaches find applications in various medical fields, including oncology, the management of conditions like muscular dystrophy and muscular disorders, and the treatment of rare diseases. They are implemented by end-users, including hospitals, clinics, academic institutions, and research centers, where cutting-edge research and development efforts are often carried out.

The nucleic acid-based gene therapy market research report is one of a series of new reports from The Business Research Company that provides nucleic acid-based gene therapy market statistics, including nucleic acid-based gene therapy industry global market size, regional shares, competitors with a nucleic acid-based gene therapy market share, detailed nucleic acid-based gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid-based gene therapy industry. This nucleic acid-based gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid based gene therapy market size has grown strongly in recent years. It will grow from $0.81 billion in 2024 to $0.88 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to growing understanding of human genetics, growing demand for personalized medicine, expanding pipeline of gene therapy products, growing government support for gene therapy, genetic disorders, cancer therapy.

The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to expanding indications, increased funding, patient advocacy and awareness, growing investment in gene therapy research and development, expanding scope of gene therapy applications, rare diseases. Major trends in the forecast period include ex vivo gene editing, advances in in vivo gene editing, combination therapies, targeted delivery systems, gene editing for rare diseases, non-viral vectors.

The nucleic acid-based gene therapy market is expected to experience increased demand due to growing financial support from both governments and companies. Nucleic acid therapeutics, which mimic naturally occurring acids or proteins responsible for genetic expression, offer a promising approach to treating diseases such as cystic fibrosis, hemophilia, sickle cell anemia, thalassemia, and diabetes, for which traditional therapies lack a cure. These therapies target the genetic basis of diseases and hold the potential for permanent solutions. For example, the National Institute of Health (NIH) announced a $34 million annual investment over five years in August 2022 to advance HIV treatment research. Such government support and investments in gene therapies are expected to boost the nucleic acid-based gene therapy market.

The expanding healthcare expenditure is set to drive the future growth of the nucleic acid gene therapy market. Healthcare expenditure encompasses the total spending on healthcare-related goods and services within a healthcare system or economy and plays a critical role in supporting the development and accessibility of nucleic acid gene therapy. In 2022, healthcare expenditure in the United States increased by 0.8%, reaching $331 billion, up from 7.6% in 2021, as reported by the Canadian Institute for Health Information. This rise in healthcare spending contributes to the growth of the nucleic acid gene therapy market.

Companies operating in the nucleic acid-based gene therapy market are strategically pursuing partnerships and collaborations to enhance production and expand their market reach. Major players are joining forces to leverage their resources and explore new avenues for research and development. For example, Pfizer Inc. and Beam Therapeutics Inc. announced an exclusive four-year research collaboration in January 2022, focused on in vivo base editing programs targeting rare genetic diseases of the liver, muscle, and central nervous system. Similarly, in August 2022, Merck and Orna Therapeutics entered into a collaboration agreement to discover, develop, and commercialize programs, including vaccines and therapeutics, in the areas of infectious disease and oncology, utilizing Orna Therapeutics' engineered circular RNA (oRNA) therapies.

In March 2023, Moderna, Inc., a US-based biotechnology company, announced a partnership with Generation Bio. This collaboration aims to develop innovative nucleic acid therapeutics, including therapies designed to target immune cells, to advance both companies' pipelines of non-viral genetic medicines. Under the agreement, Moderna will fund all research and development activities related to this partnership, including a pre-payment to support research efforts. Generation Bio, also a US-based biotechnology company, specializes in nucleic acid-based gene therapies.

Major companies operating in the nucleic acid based gene therapy market include Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics PLC, Precision BioSciences Inc., REGENXBIO Inc.

North America was the largest region in the nucleic acid-based gene therapy market in 2024. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the nucleic acid based gene therapy market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The nucleic acid based gene therapy market consists of sales of nucleic acid based gene therapy technologies such as anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleic Acid Based Gene Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nucleic acid based gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nucleic acid based gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nucleic acid based gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Anti-Sence and Anti-Gene; Short Inhibitory Sequences; Gene Transfer Therapy; Nucleoside Analogs; Ribozymes; Aptamers; Other Technologies
• 2) By Application: Oncology; Muscular Dystrophy/ Muscular Disorders; Rare Diseases
• 3) By End User: Hospitals And Clinics; Academic And Research Institutes
• Subsegments:
• 1) By Anti-Sense And Anti-Gene: Oligonucleotide Therapeutics; Peptide Nucleic Acids (PNA); Morpholino Oligomers (MO)
• 2) By Short Inhibitory Sequences (siRNA): Synthetic siRNA; Encapsulation/Delivery Systems for siRNA; Target-specific siRNA Therapies
• 3) By Gene Transfer Therapy: Viral Vectors (Adenovirus, Lentivirus, Retrovirus, AAV); Non-Viral Vectors (Liposomes, Electroporation, Gene Gun)
• 4) By Nucleoside Analogs: Purine Analogs; Pyrimidine Analogs
• 5) By Ribozymes: Trans-Splicing Ribozymes; Hammerhead Ribozymes
• 6) By Aptamers: RNA Aptamers; DNA Aptamers; Small Molecule Binding Aptamers
• 7) By Other Technologies: CRISPR-based Gene Editing; Zinc Finger Nucleases (ZFN); Transcription Activator-Like Effector Nucleases (TALENs)
• Companies Mentioned: Celsion Corporation; Wave Life Sciences; Imugene Ltd.; Caperna LLC; Phylogica Limited
• Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nucleic Acid Based Gene Therapy Market Characteristics

3. Nucleic Acid Based Gene Therapy Market Trends And Strategies

4. Nucleic Acid Based Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Nucleic Acid Based Gene Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nucleic Acid Based Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nucleic Acid Based Gene Therapy Market Growth Rate Analysis
• 5.4. Global Nucleic Acid Based Gene Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nucleic Acid Based Gene Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nucleic Acid Based Gene Therapy Total Addressable Market (TAM)

6. Nucleic Acid Based Gene Therapy Market Segmentation

• 6.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.4. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Anti-Sense And Anti-Gene, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.5. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Short Inhibitory Sequences (siRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.6. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Gene Transfer Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.7. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Nucleoside Analogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.8. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Ribozymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.9. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 6.10. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7. Nucleic Acid Based Gene Therapy Market Regional And Country Analysis

• 7.1. Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nucleic Acid Based Gene Therapy Market

• 8.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview
• 8.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nucleic Acid Based Gene Therapy Market

• 9.1. China Nucleic Acid Based Gene Therapy Market Overview
• 9.2. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nucleic Acid Based Gene Therapy Market

• 10.1. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nucleic Acid Based Gene Therapy Market

• 11.1. Japan Nucleic Acid Based Gene Therapy Market Overview
• 11.2. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nucleic Acid Based Gene Therapy Market

• 12.1. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nucleic Acid Based Gene Therapy Market

• 13.1. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nucleic Acid Based Gene Therapy Market

• 14.1. South Korea Nucleic Acid Based Gene Therapy Market Overview
• 14.2. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Bangladesh Nucleic Acid Based Gene Therapy Market

• 15.1. Bangladesh Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Bangladesh Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Bangladesh Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. Thailand Nucleic Acid Based Gene Therapy Market

• 16.1. Thailand Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. Thailand Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. Thailand Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Vietnam Nucleic Acid Based Gene Therapy Market

• 17.1. Vietnam Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Vietnam Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Vietnam Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. Malaysia Nucleic Acid Based Gene Therapy Market

• 18.1. Malaysia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. Malaysia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. Malaysia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Singapore Nucleic Acid Based Gene Therapy Market

• 19.1. Singapore Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Singapore Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Singapore Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Philippines Nucleic Acid Based Gene Therapy Market

• 20.1. Philippines Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Philippines Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Philippines Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Hong Kong Nucleic Acid Based Gene Therapy Market

• 21.1. Hong Kong Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.2. Hong Kong Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Hong Kong Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. New Zealand Nucleic Acid Based Gene Therapy Market

• 22.1. New Zealand Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. New Zealand Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. New Zealand Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. Western Europe Nucleic Acid Based Gene Therapy Market

• 23.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview
• 23.2. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. UK Nucleic Acid Based Gene Therapy Market

• 24.1. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.2. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. UK Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Germany Nucleic Acid Based Gene Therapy Market

• 25.1. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.2. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. France Nucleic Acid Based Gene Therapy Market

• 26.1. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.2. France Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. France Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Italy Nucleic Acid Based Gene Therapy Market

• 27.1. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Spain Nucleic Acid Based Gene Therapy Market

• 28.1. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.2. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Spain Nucleic Acid Based Gene Therapy Market

• 29.1. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.2. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Austria Nucleic Acid Based Gene Therapy Market

• 30.1. Austria Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 30.2. Austria Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 30.3. Austria Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

31. Belgium Nucleic Acid Based Gene Therapy Market

• 31.1. Belgium Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 31.2. Belgium Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 31.3. Belgium Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

32. Denmark Nucleic Acid Based Gene Therapy Market

• 32.1. Denmark Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 32.2. Denmark Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 32.3. Denmark Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

33. Finland Nucleic Acid Based Gene Therapy Market

• 33.1. Finland Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 33.2. Finland Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 33.3. Finland Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

34. Ireland Nucleic Acid Based Gene Therapy Market

• 34.1. Ireland Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 34.2. Ireland Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 34.3. Ireland Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

35. Netherlands Nucleic Acid Based Gene Therapy Market

• 35.1. Netherlands Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 35.2. Netherlands Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 35.3. Netherlands Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

36. Norway Nucleic Acid Based Gene Therapy Market

• 36.1. Norway Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 36.2. Norway Nucleic Acid Based Gene Therapy Market, Segmenta